View Author
scopus: 7003471690

Oosterwijk, J.C.

(Jan Oosterwijk)


cancer cancer risks breast result variant heredity likelihood perception family counselee study likelihood information mutation heredity model outcome brca 1 breast cancer dna test result table interpretation recollection variable testing tumor number relative impact brca 2 genet counsellee surveillance women scale netherland counseling mammography dna test results unclassi fied variant center university perception variables dna testing patient effect genetic analyses mediation proband signi communication change probability analysis mastectomy department cancer risk intention question citation purposes page number unclassi outcome variables risk perception decision surgery method ovarie pedigree counselor cutoff point psychol van asperen cj / patient education genotype figure co-segregation ficant difference relationship




8 Most Recent Publications

Optimal age to start preventive measures in women with BRCA1/2 mutations or high familial breast cancer risk (Article)
Tilanus-Linthorst, M.M.A. Roozenbeek, B. Eeles, R. Oosterwijk, J.C. Leach, M.O. Steyerberg, E.W. Evans, D.G. Thompson, D. Kaas, R. Manders, P. Asperen, C.J. van Adank, M.A. Hooning, M. Kwan Lim, G.E.
2013-07-01
Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result (Article)
Vos, J. Gómez García, E.B. Oosterwijk, J.C. Menko, F. Stoel, R.D. Asperen, C.J. van Jansen, A.M. Stiggelbout, A.M. Tibben, A.
2012-01-01
Exploring the short-term impact of DNA-testing in breast cancer patients: The counselees' perception matters, but the actual BRCA1/2 result does not (Article)
Vos, J. Oosterwijk, J.C. Gómez García, E.B. Menko, F. Collee, J.M. Asperen, C.J. van Jansen, A.M. Stiggelbout, A.M. Tibben, A.
2011-06-20
Perceiving cancer-risks and heredity-likelihood in genetic-counseling: How counselees recall and interpret BRCA 1/2-test results (Article)
Vos, J. Oosterwijk, J.C. Gómez García, E.B. Menko, F. Jansen, A.M. Stoel, R.D. Asperen, C.J. van Tibben, A. Stiggelbout, A.M.
2011-03-01
A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example (Article)
Mohammadi, L. Vreeswijk, M.P. Dommering, C.J. Gille, J.J. Verhoef, S. Hogervorst, F.B.L. Os, T.A.M. van Gómez García, E.B. Blok, M.J. Wijnen, J.T. Helmer, Q. Devilee, P. Oldenburg, R. Asperen, C.J. van Houwelingen, H.C. van Ouweland, A.M.W. van den Oosterwijk, J.C. Hout, A.H. van der Hoogerbrugge, N. Ligtenberg, M. Ausems, M.G.E.M. Luijt, R.B. van der
2009-06-29
A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history (Article)
Gómez García, E.B. Oosterwijk, J.C. Os, T.A.M. van Hout, A.H. van der Ligtenberg, M. Ouweland, A.M.W. van den Luijt, R.B. van der Wijnen, J.T. Gille, J.J.P. Lindsey, P.J. Devilee, P. Blok, M.J. Timmermans, M. Vreeswijk, M.P. Asperen, C.J. van Hogervorst, F.B.L. Hoogerbrugge, N. Oldenburg, R. Verhoef, S. Dommering, C.J. Ausems, M.G.E.M.
2009-02-06
Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer (Article)
Kriege, M. Brekelmans, C.T. Tilanus-Linthorst, M.M.A. Seynaeve, C.M. Bartels, C.C.M. Meijer, S. Oosterwijk, J.C. Hoogerbrugge, N. Tollenaar, R.A.E.M. Koning, H.J. de Rutgers, E.J.T. Klijn, J.G.M. Peterse, H. Obdeijn, I.M. Boetes, C. Zonderland, H.M. Muller, S.H. Kok, T. Manoliu, R.A. Besnard, A.P.E.
2007-05-01
Keratosis pilaris atrophicans: One heterogeneous disease or a symptom in different clinical entities? (Article)
Oranje, A.P. Osch, L.D.M. van Oosterwijk, J.C.
1994-04-25